Eywa Biotech founder and CEO Victoria Costa Paz explains why bringing psychedelic medicine into mainstream mental health care requires far more than producing pharmaceutical-grade psilocybin. She shares how Eywa is combining biosynthesis, patient tracking, professional education, and treatment infrastructure to build a system around a new model of mental health care.

Trent Dingman on Building Future Machines Beyond the Traditional Factory
34:43

Hooman Tavakolian on Why No One Is Really Self-Made
27:43

Robert Saltz on Why Creative Talent Is Only the Starting Point of a Career
34:56